A recent episode of BioTechNation features Dr. David Bearss, CEO of Halia Therapeutic. Bearss discusses inflammation and unveils the potential of the inflammasome in treating diseases where inflammation plays a critical role, such as Alzheimers.

Listen In ยป

Post navigation